Search Within

Jae Hong Park

  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (26)
  2. Journal Article (14)
  3. Research Letter (2)
Groups
  1. Adult Leukemia (42)
  2. CTCR Scholars (42)
  3. Center for Hematologic Malignancies (42)
  4. Department of Medicine (42)
  5. Hematologic Malignancies, Division of (42)
  6. MSK Grad Students (42)

More Groups

People
  1. Miguel-Angel Perales (41)
  2. Maria Palomba (39)
  3. Gunjan Shah (38)
  4. Michael Scordo (38)
  5. Parastoo Dahi (38)
  6. Roni Shouval (31)

More People

Years
  1. 2025 (4)
  2. 2024 (8)
  3. 2023 (10)
  4. 2022 (6)
  5. 2021 (4)
  6. 2020 (5)

More Years

Publications
  1. Blood (16)
  2. Transplantation and Cellular Therapy (5)
  3. International Journal of Radiation Oncology, Biology, Physics (4)
  4. Blood Advances (3)
  5. Bone Marrow Transplantation (3)
  6. British Journal of Haematology (2)

More Publications

Publishers
  1. American Society of Hematology (19)
  2. Elsevier Inc. (10)
  3. Nature Publishing Group (5)
  4. John Wiley & Sons (2)
  5. American Association for Cancer Research (1)
  6. Biomed Central Ltd (1)

More Publishers

Results (42)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lesion characteristics and patterns of failure in diffuse large B cell lymphoma patients treated with bridging radiotherapy prior to chimeric antigen receptor T cell therapy
    Meeting Abstract

    Hubbeling, H.; Silverman, E. A.; Wijetunga, N. A.; Palomba, M. L.; Tringale, K.; Lebow, E.; Tomas, A. A.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells
    Journal Article

    Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J. R.; Shouval, R.; Alarcon Tomas, A.; Silverberg, M. L.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Devlin, S. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Clinical impact of bridging therapy prior to commercial chimeric antigen receptor (CAR) T-cell therapies for relapsed/refractory lymphomas
    Meeting Abstract

    Imber, B. S.; Perales, M. A.; Flynn, J.; Ruiz, J. D.; Devlin, S.; Alarcon Tomas, A.; Hajj, C.; Batlevi, C. L.; Dahi, P. B.; Lin, R. J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • International prognostic index predicts outcomes in patients with relapsed and refractory large diffuse B cell lymphoma treated with commercial CAR T cells
    Meeting Abstract

    Garcia-Recio, M.; Wudhikarn, K.; Pennisi, M.; Alonso-Trillo, R.; Flynn, J.; Roni, S.; Batlevi, Y.; Silverberg, M. L.; Batlevi, C. W.; Brentjens, R.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy
    Journal Article

    Imber, B. S.; Sadelain, M.; DeSelm, C.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Giralt, S.; Park, J. H.; Sauter, C.; Scordo, M.; more...
    British Journal of Haematology (2020)

    Fulltext@MSK | Save
  • Comparing car T cells toxicities grading systems: Application of ASTCT grading system and implications for management
    Meeting Abstract

    Pennisi, M.; Jain, T.; Mead, E.; Santomasso, B.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Devlin, S. M.; Batlevi, C. W.; Brentjens, R.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparing CAR T-cell toxicity grading systems: Application of the ASTCT grading system and implications for management
    Journal Article

    Pennisi, M.; Jain, T.; Santomasso, B. D.; Mead, E.; Wudhikarn, K.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Devlin, S. M.; Batlevi, C.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Comparing gradings of immune effector cells toxicities: Application of ASTCT consensus grading system and implications for clinical management
    Meeting Abstract

    Pennisi, M.; Jain, T.; Mead, E.; Santomasso, B.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. L.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • EASIX and modified-EASIX are early predictors of severe cytokine release syndrome and neurotoxicity in patients treated with chimeric antigen receptor T cells
    Meeting Abstract

    Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J.; Maloy, M. A.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; Devlin, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Early experience using radiotherapy as a salvage treatment for relapsed or refractory non-Hodgkin lymphomas following CD19 chimeric antigen receptor modified T-cell therapy
    Meeting Abstract

    Imber, B.; Palomba, M. L.; DeSelm, C.; Dahi, P. B.; Sauter, C. S.; Scordo, M.; Batlevi, C. L.; Park, J. H.; Shah, G. L.; Giralt, S. A.; more...
    Blood (2019)

    Fulltext@MSK | Save